Kyrgyzstan has begun a new phase of a population seroepidemiological study aimed at assessing the population's immunity to vaccine-preventable infections, as well as zoonotic and natural-focal infections.
Assessing immunity and the goals of the study
This study continues an international project being carried out in five countries: Belarus, Kyrgyzstan, Armenia, Turkmenistan and Serbia. According to the Republican Center for Health Promotion, the results will help forecast the epidemiological situation in the country.
What the previous phase revealed
In the previous phase of the project, 6,600 volunteers from Kyrgyzstan took part. Their antibody levels to the causative agents of measles, rubella, mumps, COVID-19 and viral hepatitis were determined.
The data obtained have already made it possible to identify problems typical of the region, including insufficient immunity levels in certain population groups and the need to improve disease prevention through vaccination.
Prospects for the new phase
The new phase of research, planned for 2026–2028, will make it possible to assess the dynamics of population immunity to infections against which catch-up (additional) vaccination campaigns are conducted. In addition, objective data are expected on the actual prevalence of the relevant zoonotic and natural-focal infections.
